https___antibiotic.ecdc.europa.eu_ga_search_f_5B0_5D_audience_3A8_f_5B1_5D_audience_3A1823_f_5B2_5D_output_types_3A1316_f_5B3_5D_output_types_3A1421_f_5B4_5D_output_types_3A1424_1.xml
1.1 2.1 3.1 4.1 4.2 5.1 6.1 7.1 8.1 9.1 10.1 10.2 10.3 11.1 12.1 13.1 14.1 15.1 15.2 15.3 16.1 17.1 17.2 17.3 18.1 19.1 20.1 20.2 20.3 21.1 22.1 23.1 24.1 24.2 25.1 26.1 26.2 27.1 28.1 29.1 30.1 31.1 32.1 32.2
European Antibiotic Awareness Day (EAAD) 2020 EAAD will be marked on Wednesday 18 November 2020, in partnership with WHO’s World Antibiotic Awareness Week (18-24 November 2020). Antimicrobial resistance and consumption remains high in the EU/EEA and the UK, according to new ECDC data New data released today by ECDC show that levels of antimicrobial resistance and antimicrobial consumption in the EU/EEA and the UK are still of concern, particularly in the southern and eastern parts of Europe. ECDC is today launching its 2020 digital campaign to further raise awareness among health professionals and the public of the importance of continuing the fight against antimicrobial resistance to preserve the effectiveness of antimicrobials. Annual updates on antimicrobial resistance and antimicrobial consumption Digital campaign Due to the COVID-19 pandemic, EAAD will this year be marked with a digital campaign, in partnership with the World Antimicrobial Awareness Week (WAAW), during the week of 18-24 November 2020, with a special focus on 18 November with the theme: “In times of COVID-19, don’t give up on antimicrobial resistance (AMR) and stay united to preserve antimicrobials”. Video statements As part of the European Antibiotics Awareness Day (EAAD) digital campaign, ECDC has collated a series of filmed statements by high-level stakeholders from the European Commission and the German presidency of the Council of the European Union, as well as experts. Each video addresses a number of key issues in relation to antimicrobial resistance. The videos will be released and promoted on social media in connection with EAAD on 18 November under the hashtags #EAAD and #KeepAntibioticsWorking. Antibiotic Resistance | What can you do as a healthcare specialist? ECDC's new animation focusses on what healthcare professionals can do to keep antibiotics working. Social media campaign Twitter storm On Wednesday 18 November, at 15.00 CET, ECDC and organisations from around the globe will tweet about #AntibioticResistance and #WAAW. Post through your Twitter account at that time or during the day! Find out more Get involved on social media Find our online channels, add hashtags, use our frames, or take part in the Facebook/Twitter live. Find all you need for your social media communication, join the action and spread the news! Get involved Eurosurveillance editorial Will coronavirus disease (COVID-19) have an impact on antimicrobial resistance? "The COVID-19 pandemic reminds us that compliance with IPC measures is critical to ensure the safety of hospitalised patients. Most IPC measures that are essential for controlling the spread of SARS-CoV-2 also contribute to reducing the spread of antimicrobial-resistant bacteria; these, together with antimicrobial stewardship programmes, must be maintained and strengthened. In the midst of the COVID-19 pandemic, we certainly must not give up on our efforts to prevent and control AMR and must stay united to preserve the effectiveness of antimicrobials." Translated campaign materials Facts and infographics on antimicrobial resistance in healthcare settings based on the last-year point prevalence surveys in all EU/EEA languages. Key messages: Antimicrobial use in healthcare settings The key messages are based on two point prevalence surveys conducted by ECDC in 2016-2017. Read more Key messages: Health burden of antibiotic resistance The key messages are based on an article published in The Lancet Infectious Diseases. The article estimates the burden of five types of infections caused by antibiotic-resistant bacteriaRead more Healthcare-associated infections – a threat to patient safety in Europe A total of 8.9 million HAIs were estimated to occur each year in European hospitals and long-term care facilitiesRead more Antimicrobial use in: Long-term care facilities 7 / 10 antimicrobials were prescribed for treatment of an infection and 3 in 10 for prophylaxis. Antimicrobial use in European hospitals and long-term care facilities 1 in 3 patients received at least one antimicrobial on any given day. Some of this use may be unnecessary and contribute to the spread of antimicrobial resistance.
1.1 2.1 3.1 4.1 5.1 6.1 7.1 8.1 9.1 10.1 11.1 12.1 13.1 14.1 15.1 15.2 16.1 17.1 18.1 19.1 20.1 21.1 22.1 23.1 24.1 25.1 26.1 27.1 28.1 29.1 30.1 31.1
Cuardaigh Data Frithsheasmhacht in aghaidh antaibheathach – bagairt mhéadaitheach ar shláinte an duine Tá an t-ualach a bhaineann le hionfhabhtuithe ina bhfuil baictéir atá frithsheasmhach in aghaidh antaibheathach ar dhaonra na hEorpa inchomparáide leis an bhfliú, leis an eitinn agus le VEID/SEIF ar fad le chéile. Data Úsáid ábhar frithmhiocróbach in ospidéil Eorpacha agus in áiseanna cúraim fhadtéarmaigh Fuair 1 othar as gach 3 otharábhar frithmhiocróbach amháin ar a laghad ar aon lá áirithe. Data Ionfhabhtuithe a bhaineann le cúram sláinte – bagairt ar shábháilteacht othar san Eoraip Meastar gur tharla 8.9 milliún ionfhabhtú a bhain le cúram sláinte gach bliain in ospidéil san Eoraip agus in áiseanna cúraim fhadtéarmaigh araon. Data Úsáid fhrithmhiocróbach in: Saoráidí cúraim fhadtéarmaigh Ordaíodh 7 as 10 gcinn de fhrithmhiocróbáin chun ionfhabhtú a chóireáil agus tugadh 3 as 10 gcinn acu le haghaidh próifiolacsais. Data An cosaint éifeachtach é seo i gcoinne slaghdán agus fliú? Ní hiad antaibheathaigh ach an oiread. Antaibheathaigh. Bain úsáid astu go cliste - agus gan i gcoinne slaghdán agus fliú riamh. Data Antaibheathaigh - bí freagrach Mínítear sa ghrafaic faisnéise cad is frithsheasmhacht in aghaidh antaibheathach ann agus leagtar béim inti ar na fadhbanna atá le sárú againn de bharr frithsheasmhacht in aghaidh antaibheathach agus úsáid antaibheathach ag daoine – in ospidéil agus sa phobal araon. Data Conas a scaiptear frithsheasmhacht in aghaidh antaibheathach? Mínítear sa ghrafaic faisnéise seo conas a leathann frithsheasmhacht in aghaidh antaibheathach i bhfeirmeoireacht ainmhithe, sa phobal, i saoráidí cúram sláinte agus de bharr taistil. Data Frithsheasmhacht in aghaidh ábhair fhrithmhiocróbacha san Eoraip: 2014 Forbhreathnú ar na sonraí a eisíodh sa bhliain 2014 maidir le frithsheasmhacht in aghaidh ábhair fhrithmhiocróbacha Data Frithsheasmhacht mhéadaitheach in aghaidh antaibheathaigh líne deiridh: 2013 Mór-aicme líne deiridh antaibheathach a úsáidtear chun cóireáil a chur in aghaidh ionfhabhtuithe baictéaracha is ea carbaipeineimí.